PCDHGA9 and gastric cancer: Interestingly, compared with either element alone, the combination of PCDHGA9 expression and promoter hypermethylation reached a higher statistical significance in estimating MFS (p = 0.004), which may provide individual GC patients with a more precise appraisal of metastatic risk.